Prognosis and results of treatment of patients with terminal stage peritonitis | Ukrainian Medical Journal

Materials and methods. In 2019–2022, 1083 patients with peritonitis of various genesis were treated in the surgical department of the Brovary Multidisciplinary Clinical Hospital. Among them there were 557 (51.4%) men, and 526 (48.6%) women. 528 (48.7%) patients had a reactive stage of peritonitis, 499 (46.1%) had a toxic stage, and 56 (5.2%) had a terminal stage. We interpreted the terminal stage of peritonitis as abdominal sepsis.

Results. During all years of the study, the majority of patients were in the range of 10–19 points according to the modified APACHE II scale. A significant part of patients was in the range of 20–30 points, which emphasizes the severity of the condition of this category of patients. 15 (26.8%) patients died. 32.1% of patients were hospitalized more than 4 days after the onset of the disease. The vast majority of patients (87.5%) sought help later than 24 hours after the onset of illness.

Conclusion. Treatment of patients with end-stage peritonitis should be carried out in accordance with the recommendations for the treatment of sepsis. The development of abdominal sepsis, first of all, is associated with the late application of patients for medical help. Therefore, family doctors should inform patients about peritonitis and its symptoms, which should be immediately referred to a doctor.

References

1. Cecconi M., Evans L., Levy M., Rhodes A. (2018) Sepsis and septic shock. Lancet, 392(10141): 75–87. doi: 10.1016/S0140-6736(18)30696-2.
2. Singer M., Deutschman C.S., Seymour C.W. et al. (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA, 315(8): 801–810. doi: 10.1001/jama.2016.0287.
3. Vincent J.L., Moreno R., Takala J. et al. (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med., 22(7): 707–710. doi: 10.1007/BF01709751.
4. Raith E.P., Udy A.A., Bailey M. et al. (2017) Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA, 317(3): 290–300.
5. Hecker A., Reichert M., Reuß C.J. et al. (2019) Intra-abdominal sepsis: new definitions and current clinical standards. Langenbecks Arch. Surg., 404(3): 257–271.
6. Cox M.C., Brakenridge S.C., Stortz J.A. et al. (2020) Abdominal sepsis patients have a high incidence of chronic critical illness with dismal long-term outcomes. Am. J. Surg., 220(6): 1467–1474. doi: 10.1016/j.amjsurg.2020.07.016.
7. Biliaieva O.O., Karol I.V. (2022) Suchasni aspekty prohnozuvannia perebihu hostroho perytonitu. Kharkivska khirurhichna shkola, 1(112): 65–70.
8. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. (1985) APACHE-II: a severity of disease classification system. Crit. Care Med., 13(10): 818–829.
9. Bader F.G., Schröder M., Kujath P. et al. (2009) Diffuse postoperative peritonitis — value of diagnostic parameters and impact of early indication for relaparotomy. Eur. J. Med. Res., 14(11): 491–496. doi: 10.1186/2047-783x-14-11-491.
10. Solomkin J.S., Mazuski J.E., Bradley J.S. et al. (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg. Infect. (Larchmt), 11(1): 79–109. doi: 10.1089/sur.2009.9930.
11. Welsch T., Frommhold K., Hinz U. et al. (2008) Persisting elevation of C-reactive protein after pancreatic resections can indicate developing inflammatory complications. Surgery, 143(1): 20–28. doi: 10.1016/j.surg.2007.06.010.
12. Parlato M., Philippart F., Rouquette A. et al. (2018) Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study. Intensive Care Med., 44(7): 1061–1070.
13. Heyland D.K., Johnson A.P., Reynolds S.C., Muscedere J. (2011) Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit. Care Med., 39(7): 1792–1799.
14. De Jong E., van Oers J.A., Beishuizen A. et al. (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis., 16(7): 819–827. doi: 10.1016/S1473-3099(16)00053-0.
15. Riché F., Gayat E., Collet C. et al. (2013) Local and systemic innate immune response to secondary human peritonitis. Crit. Care, 17(5): R201. doi: 10.1186/cc12895.
16. Hecker A., Uhle F., Schwandner T. et al. (2014) Diagnostics, therapy and outcome prediction in abdominal sepsis: current standards and future perspectives. Langenbecks Arch. Surg., 399(1): 11–22. doi: 10.1007/s00423-013-1132-z.